# REmifentanil And Dexmedetomidine for EarlY Intensive Blood Pressure Lowering in ICH.

> **NCT07695220** · NA · NOT_YET_RECRUITING · sponsor: **The Third Affiliated Hospital of Southern Medical University** · enrollment: 1116 (estimated)

## Conditions studied

- Intracerebral Hemorrhage

## Interventions

- **DRUG:** Remifentanil and Dexmedetomidine
- **DRUG:** Guideline standard care

## Key facts

- **NCT ID:** NCT07695220
- **Lead sponsor:** The Third Affiliated Hospital of Southern Medical University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 1116 (ESTIMATED)
- **Last updated:** 2026-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07695220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07695220, "REmifentanil And Dexmedetomidine for EarlY Intensive Blood Pressure Lowering in ICH.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07695220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*